Literature DB >> 10341454

A global collaboration on carcinogenicity screening in transgenic mouse models.

R Forster1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10341454     DOI： 10.1023/a:1008889427323

Source DB:  PubMed          Journal:  Transgenic Res        ISSN： 0962-8819            Impact factor:   2.788


× No keyword cloud information.
  10 in total

1.  Mouse liver carcinogenesis: mechanisms and relevance.

Authors:  J I Goodman; J M Ward; J A Popp; J E Klaunig; T R Fox
Journal:  Fundam Appl Toxicol       Date:  1991-11

2.  Spontaneous liver tumors and benzo[a]pyrene-induced lymphomas in XPA-deficient mice.

Authors:  A de Vries; C T van Oostrom; P M Dortant; R B Beems; C F van Kreijl; P J Capel; H van Steeg
Journal:  Mol Carcinog       Date:  1997-05       Impact factor: 4.784

3.  Carcinogenicity testing--a national catastrophe.

Authors:  E G Feldmann
Journal:  J Pharm Sci       Date:  1980-02       Impact factor: 3.534

4.  Chemical carcinogenesis: too many rodent carcinogens.

Authors:  B N Ames; L S Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

6.  Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes.

Authors:  A Saitoh; M Kimura; R Takahashi; M Yokoyama; T Nomura; M Izawa; T Sekiya; S Nishimura; M Katsuki
Journal:  Oncogene       Date:  1990-08       Impact factor: 9.867

7.  v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid.

Authors:  A Leder; A Kuo; R D Cardiff; E Sinn; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 8.  A critical appraisal of the value of the mouse cancer bioassay in safety assessment.

Authors:  C L Alden; P F Smith; C E Piper; L Brej
Journal:  Toxicol Pathol       Date:  1996 Nov-Dec       Impact factor: 1.902

9.  An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. II. A genotypic marker that predicts tumorigenic responsiveness.

Authors:  K L Thompson; B A Rosenzweig; F D Sistare
Journal:  Toxicol Pathol       Date:  1998 Jul-Aug       Impact factor: 1.902

Review 10.  How useful are chronic (life-span) toxicology studies in rodents in identifying pharmaceuticals that pose a carcinogenic risk to humans?

Authors:  A Monro
Journal:  Adverse Drug React Toxicol Rev       Date:  1993
  10 in total
  1 in total

Review 1.  The use of genetically modified mice in cancer risk assessment: challenges and limitations.

Authors:  David A Eastmond; Suryanarayana V Vulimiri; John E French; Babasaheb Sonawane
Journal:  Crit Rev Toxicol       Date:  2013-09       Impact factor: 5.635
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.